Oruka Therapeutics

Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases.

Launch date

Feb 2024

Employees

Waltham Massachusetts (HQ)

Date	Investors	Amount	Round
Apr 2024*	Paragon Therapeutics	N/A	Corporate spinout
Apr 2024*	N/A	N/A	IPO
Apr 2024*	Venrock Fairmount Partners	$275m	Private Placement VC
Sep 2024*	Blackstone Venrock SR One RTW Investments Janus Henderson Investors Fairmount Partners Access Biotechnology Avidity Partners Commodore Capital Affinity Asset Advisors Braidwell Paradigm BioCapital Frazier Life Sciences Allostery Investments Kalehua Capital Management	$200m	Post IPO Equity
Total Funding		€250m

ACQUISITION by Oruka Therapeutics Apr 2024

Recent News about Oruka Therapeutics